Department of Chemistry and Biochemistry, Institute for Cellular and Molecular Biology, The University of Texas, 2500 Speedway, Austin, Texas 78712, USA.
Biochemistry. 2011 Jul 26;50(29):6376-86. doi: 10.1021/bi200280r. Epub 2011 Jul 5.
The human mitochondrial DNA polymerase (pol γ) is responsible for the replication of the mitochondrial genome. Mutation Y955C in the active site of pol γ results in early onset progressive external ophthalmoplegia, premature ovarian failure, and Parkinson's disease. In single-turnover kinetic studies, we show that the Y955C mutation results in a decrease in the maximal rate of polymerization and an increase in the K(m) for correct incorporation. The mutation decreased the specificity constant for correct incorporation of dGTP, TTP, and ATP to values of 1.5, 0.35, and 0.044 μM(-1) s(-1), respectively, representing reductions of 30-, 110-, and 1300-fold, respectively, relative to the value for the wild-type enzyme. The fidelity of incorporation was reduced 6-130-fold, largely because of the significant decrease in the specificity constant for correct dATP:T incorporation. For example, k(cat)/K(m) for forming a TTP:T mismatch was decreased 10-fold from 0.0002 to 0.00002 μM(-1) s(-1) by the Y955C mutant, but the 1300-fold slower incorporation of the correct dATP:T relative to that of the wild type led to a 130-fold lower fidelity. While correct incorporation of 8-oxo-dGTP was largely unchanged, the level of incorporation of 8-oxo-dG with dA in the template strand was reduced 500-fold. These results support a role for Y955 in stabilizing A:T base pairs at the active site of pol γ and suggest that the severe clinical symptoms of patients with this mutation may be due, in part, to the reduced efficiency of incorporation of dATP opposite T, and that the autosomal dominant phenotype may arise from the resulting higher mutation frequency.
人类线粒体 DNA 聚合酶(pol γ)负责线粒体基因组的复制。pol γ 活性位点的 Y955C 突变导致早发性进行性眼外肌麻痹、卵巢早衰和帕金森病。在单轮动力学研究中,我们表明 Y955C 突变导致聚合的最大速率降低,并且正确掺入的 K(m)增加。该突变降低了 dGTP、TTP 和 ATP 正确掺入的特异性常数,分别为 1.5、0.35 和 0.044 μM(-1) s(-1),相对于野生型酶的值分别降低了 30、110 和 1300 倍。掺入的保真度降低了 6-130 倍,这主要是因为正确 dATP:T 掺入的特异性常数显著降低。例如,形成 TTP:T 错配的 k(cat)/K(m) 由 Y955C 突变体降低了 10 倍,从 0.0002 降低至 0.00002 μM(-1) s(-1),但相对于野生型,正确 dATP:T 的掺入速度慢 1300 倍,导致保真度降低 130 倍。虽然正确掺入 8-oxo-dGTP 基本不变,但模板链中 8-oxo-dG 与 dA 的掺入水平降低了 500 倍。这些结果支持 Y955 在 pol γ 活性位点稳定 A:T 碱基对的作用,并表明该突变患者的严重临床症状可能部分归因于 dATP 与 T 配对的掺入效率降低,并且常染色体显性表型可能源于由此产生的更高突变频率。